Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1996 Dec 7;313(7070):1418–1419. doi: 10.1136/bmj.313.7070.1418

Thromboembolism in primary pulmonary hypertension.

A Bishop, P Oldershaw
PMCID: PMC2353007  PMID: 8973220

Full text

PDF
1418

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fuster V., Steele P. M., Edwards W. D., Gersh B. J., McGoon M. D., Frye R. L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984 Oct;70(4):580–587. doi: 10.1161/01.cir.70.4.580. [DOI] [PubMed] [Google Scholar]
  2. Higenbottam T., Wheeldon D., Wells F., Wallwork J. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet. 1984 May 12;1(8385):1046–1047. doi: 10.1016/s0140-6736(84)91452-1. [DOI] [PubMed] [Google Scholar]
  3. Irey N. S., Norris H. J. Intimal vascular lesions associated with female reproductive steroids. Arch Pathol. 1973 Oct;96(4):227–234. [PubMed] [Google Scholar]
  4. Kleiger R. E., Boxer M., Ingham R. E., Harrison D. C. Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest. 1976 Feb;69(2):143–147. doi: 10.1378/chest.69.2.143. [DOI] [PubMed] [Google Scholar]
  5. Moser K. M., Fedullo P. F., Finkbeiner W. E., Golden J. Do patients with primary pulmonary hypertension develop extensive central thrombi? Circulation. 1995 Feb 1;91(3):741–745. doi: 10.1161/01.cir.91.3.741. [DOI] [PubMed] [Google Scholar]
  6. Oakley C., Somerville J. Oral contraceptives and progressive pulmonary vascular disease. Lancet. 1968 Apr 27;1(7548):890–893. doi: 10.1016/s0140-6736(68)90240-7. [DOI] [PubMed] [Google Scholar]
  7. Rich S., Dantzker D. R., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., Fishman A. P., Goldring R. M., Groves B. M., Koerner S. K. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987 Aug;107(2):216–223. doi: 10.7326/0003-4819-107-2-216. [DOI] [PubMed] [Google Scholar]
  8. Rich S., Kaufmann E., Levy P. S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992 Jul 9;327(2):76–81. doi: 10.1056/NEJM199207093270203. [DOI] [PubMed] [Google Scholar]
  9. WOOD P. Pulmonary hypertension. Br Med Bull. 1952;8(4):348–353. doi: 10.1093/oxfordjournals.bmb.a074201. [DOI] [PubMed] [Google Scholar]
  10. Wagenvoort C. A., Mulder P. G. Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication? Chest. 1993 Mar;103(3):844–849. doi: 10.1378/chest.103.3.844. [DOI] [PubMed] [Google Scholar]
  11. Worsley D. F., Palevsky H. I., Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med. 1994 May;35(5):793–796. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES